Embassy of the United States New Delhi, India

What is PEPFAR?

The President's Emergency Plan for AIDS Relief (PEPFAR) is a ten-year initiative designed to turn the tide in combating the HIV/AIDS pandemic. Through PEPFAR the U.S. government hopes to help prevent 7 million new infections, treat 2 million HIV-infected people with life-saving drugs, and provide care for 10 million people with HIV, orphans, and other vulnerable children.  The first phase of PEPFAR authorized $15 billion for HIV programs around the world.  On July 30, 2008, H.R. 5501, the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 was signed into law, authorizing up to $48 billion over the next 5 years to combat global HIV/AIDS, tuberculosis, and malaria.  For more information, please visit: PEPFAR website

When was the first case of HIV reported in India?

The first case of HIV was officially reported from a clinic in the southern city of Chennai in the summer of 1986. 

What is the HIV prevalence rate in India?

According to the National Family Health Survey (NFHS-3), the national HIV prevalence rate is 0.28 percent.  The HIV prevalence among men is 0.36 percent, and among women, 0.22 percent. IN the high HIV prevalence states, however, infection rates varied from 1.13 percent in Manipur and 0.97 percent in Andhra Pradesh to 0.34 percent in Tamil Nadu. The estimate in Uttar Pradesh, a low prevalence state, is only 0.07 percent. 

What are the National AIDS Control Organization's (NACO) priority districts?

For the purpose of planning and implementation of the third National AIDS Control Programme (NACP-III), all districts in India are classified into four categories based on HIV prevalence (measured at antenatal clinics [ANC]) in the districts among different population groups for three consecutive years.  The definitions of the four categories are as follows: 

• Category A: More than 1% ANC prevalence in district in any of the sites in the last 3 years
• Category B: Less than 1% ANC prevalence in all sites during the last 3 years with more than 5% prevalence in any high risk group (HRG) site
• Category C: Less than 1% ANC prevalence in all sites during the last 3 years with less than 5% in all HRG sites, with known hot spots (migrants, truckers, large aggregation of factory workers, tourist, etc.)
• Category D: Less than 1% ANC prevalence in all sites during the last 3 years with less than 5% in all HRG sites with no known hot spots OR no or poor HIV data

For more information (PDF 679K)

PEPFAR/India Home